Novartis Venture Fund has stepped in to take the lead on a $34 million venture round for Redwood City, CA-based upstart Annexon Bioscience, which believes it has the inside track on a new treatment for Huntington’s disease.

…read more

Source: Novartis quarterbacks a $34M round for Huntington’s startup Annexon


0 No comments